Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Traditional Chinese medicine protocol study for chronic aplastic anemia
ChiCTR-TRC-11001712Phase 2Completed
- Sponsor
- State Administration of Traditional Chinese Medicine
- Start
- Jun 2011
- Countries
- 1
01
Overview
Phase 2 trial of bazhengsan and Placebo-COD Research Private Ltd in aplastic anemia (4 arms), sponsored by State Administration of Traditional Chinese Medicine. Primary endpoint: Accumulative incidence of infection. Started Jun 2011; status: completed.
02
Drugs
bazhengsanPlacebo-COD Research Private Ltd
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on ChiCTR-TRC-11001712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001712.